The Southern Medical Journal (SMJ) is the official, peer-reviewed journal of the Southern Medical Association. It has a multidisciplinary and inter-professional focus that covers a broad range of topics relevant to physicians and other healthcare specialists.
SMJ // Article
Original Article
Relationship between Baseline Physical Activity and Generalized Anxiety Disorder and Major Depressive Disorder Treatment Outcomes
Abstract
Objectives: Generalized anxiety disorder and major depressive disorder often benefit from medication and psychotherapy. Our aim was to determine whether a correlation exists between patient baseline physical activity and response to treatment.Methods: This was a retrospective study that included adult patients with anxiety and depression who received outpatient care for their conditions by providers in the Department of Psychiatry and Psychology of the Mayo Clinic in Jacksonville, Florida. Statistical analyses were used to analyze whether Rapid Assessment of Physical Activity scores as a measure of baseline exercise correlated to changes in Patient Health Questionnaire-9 (PHQ-9) scores or Generalized Anxiety Disorder-7-item scale (GAD-7) scores during treatment for anxiety or depression. Factors including age, sex, smoking status, and caffeine intake also were analyzed.
Results: When comparing change in GAD-7 or PHQ-9 scores from baseline to follow-up during treatment for anxiety or depression, there was no significant difference based on Rapid Assessment of Physical Activity scores. Caffeine intake had a direct correlation with PHQ-9 scores from baseline to 12 to 24 weeks but no correlation with GAD-7 scores.
Conclusions: Overall, the amount of physical activity a patient participates in before anxiety or depression treatment does not appear to affect improvement outcomes. Caffeine intake may improve depression severity scores; however, further research is needed to assess whether this could be a part of future treatment plans.
This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.
References
1. Bandelow B, Michaelis S. Epidemiology of anxiety disorders in the 21st century. Dialogues Clin Neurosci 2015;17:327–335.
2. Gaynes BN, Rush AJ, Trivedi MH, et al. Major depression symptoms in primary care and psychiatric care settings: a cross-sectional analysis. Ann Fam Med 2007;5:126–134.
3. Kroenke K, Spitzer RL, Williams JB, et al. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med 2007; 146:317–325.
4. National Institute of Mental Health. Mental health information. https://www.nimh.nih.gov/health. Accessed June 30, 2023.
5. Anxiety & Depression Association of America. Anxiety disorders – facts & statistics. https://adaa.org/. Accessed January 14, 2022.
6. Greenberg PE, Fournier AA, Sisitsky T, et al. The economic burden of adults with major depressive disorder in the United States (2010 and 2018). Pharmacoeconomics 2021;39:653–665.
7. DeRubeis RJ, Hollon SD, Amsterdam JD, et al. Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry 2005;62:409–416.
8. Roshanaei-Moghaddam B, Pauly MC, Atkins DC, et al. Relative effects of CBT and pharmacotherapy in depression versus anxiety: is medication somewhat better for depression, and CBT somewhat better for anxiety? Depress Anxiety 2011;28:560–567.
9. Friedman ES, Koenig AM, Thase ME. Cognitive and behavioral therapies. In: Hossein Fatemi S, Clayton PJ, eds. The Medical Basis of Psychiatry. 4th ed. New York: Springer; 2016:781–798.
10. Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet 2018;391:1357–1366.
11. Kovich H, Kim W, Quaste AM. Pharmacologic treatment of depression. Am Fam Physician 2023;107:173–181.
12. Pintor L, Torres X, Navarro V, et al. Is the type of remission after a major depressive episode an important risk factor to relapses in a 4-year follow up? J Affect Disord 2004;82:291–296.
13. Lorimer B, Kellett S, Nye A, et al. Predictors of relapse and recurrence following cognitive behavioural therapy for anxiety-related disorders: a systematic review. Cogn Behav Ther 2021;50:1–18.
14. Harvey SB, Hotopf M, Overland S, et al. Physical activity and common mental disorders. Br J Psychiatry 2010;197:357–364.
15. Knochel C, Oertel-Knochel V, O'Dwyer L, et al. Cognitive and behavioural effects of physical exercise in psychiatric patients. Prog Neurobiol 2012;96: 46–68.
16. Paluska SA, Schwenk TL. Physical activity and mental health: current concepts. Sports Med 2000;29:167–180. .
17. Carek PJ, Laibstain SE, Carek SM. Exercise for the treatment of depression and anxiety. Int J Psychiatry Med 2011;41:15–28.
18. Galper DI, Trivedi MH, Barlow CE, et al. Inverse association between physical inactivity and mental health in men and women. Med Sci Sports Exerc 2006;38:173–178.
19. Brunes A, Augestad LB, Gudmundsdottir SL. Personality, physical activity, and symptoms of anxiety and depression: the HUNT study. Soc Psychiatry Psychiatr Epidemiol 2013;48:745–756.
20. De Mello MT, de Aquino Lemos V, Moreira Antunes HK, et al. Relationship between physical activity and depression and anxiety symptoms: a population study. J Affect Disord 2013;149:241–246.
21. Richardson T, Wrightman M, Yeebo M, et al. Reliability and score ranges of the PHQ-9 and GAD-7 in a primary and secondary care mental health service. J Psychosoc Rehabil Ment Health 2017;4:237–240.
22. Topolski TD, LoGerfo J, Patrick DL, et al. The Rapid Assessment of Physical Activity (RAPA) among older adults. Prev Chronic Dis 2006;3:A118.
23. Svensson M, Brundin L, Erhardt S, et al. Physical activity is associated with lower long-term incidence of anxiety in a population-based, large-scale study. Front Psychiatry 2021;12:714014.
24. Chalder M, Wiles NJ, Campbell J, et al. Facilitated physical activity as a treatment for depressed adults: randomised controlled trial. BMJ 2012; 344:e2758.
25. Aylett E, Small N, Bower P. Exercise in the treatment of clinical anxiety in general practice - a systematic review and meta-analysis.BMC Health Serv Res 2018;18:559.
26. Kazeminia M, Salari N, Vaisi-Raygani A, et al. The effect of exercise on anxiety in the elderly worldwide: a systematic review and meta-analysis. Health Qual Life Outcomes 2020;18:363.
27. Grosso G, Micek A, Castellano S, et al. Coffee, tea, caffeine and risk of depression: a systematic review and dose-response meta-analysis of observational studies. Mol Nutr Food Res 2016;60:223–234.
28. Wang L, Shen X, Wu Y, et al. Coffee and caffeine consumption and depression: a meta-analysis of observational studies. Aust N Z J Psychiatry 2016;50:228–242.
29. Liu QS, Deng R, Fan Y, et al. Low dose of caffeine enhances the efficacy of antidepressants in major depressive disorder and the underlying neural substrates. Mol Nutr Food Res 2017;61:1600910.
30. Lara DR. Caffeine, mental health, and psychiatric disorders. J Alzheimers Dis 2010;20(suppl 1):S239–S248.
31. Guest NS, VanDusseldorp TA, Nelson MT, et al. International Society of Sports Nutrition position stand: caffeine and exercise performance. J Int Soc Sports Nutr 2021;18:1.
